Mr. Lozon joined St. Michael’s Hospital in 1991 as Chief Operating
Officer and within a year was appointed President and CEO. Under his
leadership, the Hospital underwent the most dramatic financial
turnaround in Canadian history; constructed the 17-story Cardinal
Carter wing; merged with the Wellesley Central Hospital; established
internationally renowned clinical and research programs focused on
issues impacting inner city residents; and is Read the rest of this entry »

At Home Fitness Announces Grand Opening Of Gilbert, Arizona Store
Highly anticipated grand opening of At Home Fitness store took place on beginning 2009 in Gilbert Arizona.
Gilbert, AZ (
) February 18, 2009 — To ring in the new year of 2009, At Home Fitness officially opened the doors to its Gilbert, Arizona store. Located on the corner of San Tan Village Parkway and Market Street right next door to Creative Leather, the new store offers a Read the rest of this entry »

Because forward-looking statements involve risks and uncertainties, the
Company’s actual results could differ materially from any future results,
performance or achievements expressed or implied by such forward-looking
statements. The potential risks and uncertainties which could cause actual
results to differ materially include: regulatory approvals or third party
consents may not be obtained, the impact of further changes in healthcare
reimbursement Read the rest of this entry »

The following factors, among others, could cause actual results to differ
materially from the anticipated results or other expectations expressed in the
forward-looking statement: general business and economic conditions; the
performance of financial markets and interest rates; the ability to obtain
governmental approvals of the transaction on a timely basis; the failure to
realize synergies and cost-savings from the transaction or delay in
realization Read the rest of this entry »

This news release contains forward-looking statements that are based on
the Company’s current beliefs and assumptions
and on information currently available to its management.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company’s
actual results, performance or achievements to be materially different
from any future results, performance Read the rest of this entry »

This press release contains certain “forward-looking” statements as
that term is defined in the Private Securities Litigation Reform Act
of 1995 regarding, among other things, statements relating to goals,
plans, objectives and future events. Theravance intends such
forward-looking statements to be covered by the safe harbor provisions
for forward-looking statements contained in Section 21E of the
Exchange Act and the Private Securities Litigation Read the rest of this entry »

LAKE FOREST, Ill.–(BUSINESS WIRE)–
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Food and Drug Administration has granted approval for Akorn
s Abbreviated New Drug Application (ANDA) for Adenosine Injection USP, 3 mg/mL.
Adenosine Injection is indicated for supraventricular tachycardia in cardiac patients. Annual sales for Adenosine Injection were approximately $22 million in 2007, according to IMS sales data.
Arthur S. Przybyl, Read the rest of this entry »

Minneapolis/St. Paul Fitness Together Studio Announces Healthy Lifestyle Seminar Series for 2009
Fitness Together, Minnesota's premier personal training company announces Orientation to a Healthy Lifestyle Seminar Series. This yearlong series lead by wellness professionals is packed with knowledge and action items to assist anyone with living a healthy lifestyle.
Minneapolis, MN (
) December 15, 2008 — Fitness Together, the premiere private Read the rest of this entry »

MOUNTAIN VIEW, Calif.
,
Oct. 7
/PRNewswire/ — Reliant Technologies, Inc.,
the pioneer of fractional resurfacing and market leader of aesthetic laser
skin treatments, today announced that it has received FDA 510(k) clearance for
three new Fraxel re:pair laser handpieces. These handpieces expand the
capabilities of the Fraxel re:pair laser system, providing physicians with a
complete skin resurfacing and surgical treatment option. As part of Read the rest of this entry »

(RTTNews) - 
Monday, Syneron Medical Ltd. (ELOS:
) announced its preliminary results for the third quarter. The company expects to report third-quarter net profit in the range of $3.4 million-$3.7 million or $0.11-$0.13 per share.
On average, five analysts polled by First Call/Thomson Financial currently expect the company to earn $0.27 per share for the third quarter.
Revenue for the quarter is expected in the Read the rest of this entry »